Ascendis Pharma A (ASND) Cash & Equivalents (2012 - 2026)
Ascendis Pharma A's Cash & Equivalents came in at $944.14 million for the quarter ended Jun 30, 2026, up 68.8% from $559.24 million a year earlier and up 40.8% from the prior quarter.
Powered by 
Analysis
Ascendis Pharma A (ASND) Cash & Equivalents (2012 - 2026) Analysis & Trends
As of Dec 31, 2025, Ascendis Pharma A's Cash & Equivalents was $696.01 million, up 14.9% from the prior year.
- Cash & Equivalents carries a five-year compound annual growth rate of 0.0% (years ended Dec 2020 to Dec 2025).
- Going back by year, Cash & Equivalents was $605.61 million in the year ended Dec 31, 2024 (+42.8%), $424.21 million in the year ended Dec 31, 2023 (-9.5%), $468.76 million in the year ended Dec 31, 2022 (-8.2%) and $510.52 million in the year ended Dec 31, 2021 (-26.7%).
- The figure for the quarter ended Jun 30, 2026 represents the highest quarterly Cash & Equivalents in data going back to the quarter ended Dec 31, 2012.
- Year-over-year, Cash & Equivalents has increased for three consecutive quarters, with growth averaging 43.2% over the last eight quarters.
- The fastest year-over-year change in Cash & Equivalents over five years came in the quarter ended Jun 30, 2025 (growth of 100.7%), and the weakest in the quarter ended Jun 30, 2023 (a decline of 40.2%).
- Business Quant data shows ASND's Cash & Equivalents at $670.63 million (quarter ended Mar 31, 2026), $717.1 million (quarter ended Dec 31, 2025) and $630.23 million (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Ascendis Pharma A | 14.09 Bn | 10.33 Bn | 362.22 Mn | 944.14 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 944.14 Mn |
| Mar 31, 2026 | 670.63 Mn |
| Dec 31, 2025 | 717.10 Mn |
| Sep 30, 2025 | 630.23 Mn |
| Jun 30, 2025 | 559.24 Mn |
| Mar 31, 2025 | 544.80 Mn |
| Dec 31, 2024 | 597.93 Mn |
| Sep 30, 2024 | 686.95 Mn |
| Jun 30, 2024 | 278.59 Mn |
| Mar 31, 2024 | 347.90 Mn |
| Dec 31, 2023 | 421.94 Mn |
| Sep 30, 2023 | 480.36 Mn |
| Jun 30, 2023 | 429.28 Mn |
| Mar 31, 2023 | 538.05 Mn |
| Dec 31, 2022 | 453.77 Mn |
| Sep 30, 2022 | 613.36 Mn |
| Jun 30, 2022 | 717.48 Mn |
| Mar 31, 2022 | 848.09 Mn |
| Dec 31, 2021 | 510.52 Mn |
| Sep 30, 2021 | 817.18 Mn |
API Access
Ascendis Pharma A Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ASND&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "ASND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ASND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();